These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15500897)

  • 1. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
    McFadden EP; Stabile E; Regar E; Cheneau E; Ong AT; Kinnaird T; Suddath WO; Weissman NJ; Torguson R; Kent KM; Pichard AD; Satler LF; Waksman R; Serruys PW
    Lancet; 2004 Oct 23-29; 364(9444):1519-21. PubMed ID: 15500897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent thrombosis in randomized clinical trials of drug-eluting stents.
    Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
    N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
    Daemen J; Wenaweser P; Tsuchida K; Abrecht L; Vaina S; Morger C; Kukreja N; Jüni P; Sianos G; Hellige G; van Domburg RT; Hess OM; Boersma E; Meier B; Windecker S; Serruys PW
    Lancet; 2007 Feb; 369(9562):667-78. PubMed ID: 17321312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late stent thrombosis after implantation of a sirolimus-eluting stent.
    Kerner A; Gruberg L; Kapeliovich M; Grenadier E
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):505-8. PubMed ID: 14624431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents: some bare facts.
    Eisenberg MJ
    Lancet; 2004 Oct 23-29; 364(9444):1466-7. PubMed ID: 15500872
    [No Abstract]   [Full Text] [Related]  

  • 7. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
    Kastrati A; Mehilli J; Pache J; Kaiser C; Valgimigli M; Kelbaek H; Menichelli M; Sabaté M; Suttorp MJ; Baumgart D; Seyfarth M; Pfisterer ME; Schömig A
    N Engl J Med; 2007 Mar; 356(10):1030-9. PubMed ID: 17296823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
    Stettler C; Wandel S; Allemann S; Kastrati A; Morice MC; Schömig A; Pfisterer ME; Stone GW; Leon MB; de Lezo JS; Goy JJ; Park SJ; Sabaté M; Suttorp MJ; Kelbaek H; Spaulding C; Menichelli M; Vermeersch P; Dirksen MT; Cervinka P; Petronio AS; Nordmann AJ; Diem P; Meier B; Zwahlen M; Reichenbach S; Trelle S; Windecker S; Jüni P
    Lancet; 2007 Sep; 370(9591):937-48. PubMed ID: 17869634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very late thrombosis after drug-eluting stents.
    Feres F; Costa JR; Abizaid A
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
    Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
    EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late coronary thrombosis in paclitaxel-eluting stents. Case reports.
    Cassin M; De Biasio M; Macor F; Burelli C; Vendrametto F; Driussi M; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):284-8. PubMed ID: 17413307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.
    Waters RE; Kandzari DE; Phillips HR; Crawford LE; Sketch MH
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):520-4. PubMed ID: 15973673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.
    Spaulding C; Daemen J; Boersma E; Cutlip DE; Serruys PW
    N Engl J Med; 2007 Mar; 356(10):989-97. PubMed ID: 17296825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.